|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0026764,
umls-concept:C0030705,
umls-concept:C0079611,
umls-concept:C0087111,
umls-concept:C0220901,
umls-concept:C0332293,
umls-concept:C0441833,
umls-concept:C0445501,
umls-concept:C0596382,
umls-concept:C1333683,
umls-concept:C1415041,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C2603343
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2008-5-29
|
|
pubmed:abstractText |
To analyze the prognostic impact of immunophenotyping in patients with multiple myeloma (MM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BladéJoanJ,
pubmed-author:Diaz-MediavillaJoaquínJ,
pubmed-author:GEM Study Group,
pubmed-author:GutiérrezNormaN,
pubmed-author:LahuertaJuan JJJ,
pubmed-author:MartínezRafaelR,
pubmed-author:MateoGemaG,
pubmed-author:MateosMaria VMV,
pubmed-author:MontalbánM AngelesMA,
pubmed-author:MontejanoLauraL,
pubmed-author:OjangurenJosé MJM,
pubmed-author:OrfaoAlbertoA,
pubmed-author:PETHEMA Study Group,
pubmed-author:PalomeraLuisL,
pubmed-author:RiberaJosé MJM,
pubmed-author:RosiñolLauraL,
pubmed-author:San MiguelJesús FJF,
pubmed-author:SuredaAnnaA,
pubmed-author:TerolMaria JMJ,
pubmed-author:VidrialesMaria-BelénMB,
pubmed-author:de ArribaFelipeF,
pubmed-author:de la RubiaJavierJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2737-44
|
|
pubmed:meshHeading |
pubmed-meshheading:18443352-Adult,
pubmed-meshheading:18443352-Aged,
pubmed-meshheading:18443352-Antigens, CD,
pubmed-meshheading:18443352-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18443352-Female,
pubmed-meshheading:18443352-Flow Cytometry,
pubmed-meshheading:18443352-Humans,
pubmed-meshheading:18443352-Immunophenotyping,
pubmed-meshheading:18443352-In Situ Hybridization, Fluorescence,
pubmed-meshheading:18443352-Male,
pubmed-meshheading:18443352-Middle Aged,
pubmed-meshheading:18443352-Multiple Myeloma,
pubmed-meshheading:18443352-Prognosis,
pubmed-meshheading:18443352-Proportional Hazards Models,
pubmed-meshheading:18443352-Prospective Studies,
pubmed-meshheading:18443352-Survival Rate,
pubmed-meshheading:18443352-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
|
|
pubmed:affiliation |
Hospital Universitario de Salamanca, Salamanca, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
